William Oh

William Oh, MD

  • PROFESSOR | Medicine, Hematology and Medical Oncology
  • PROFESSOR | Urology


Hematology-Oncology, Cancer (Oncology)


William K. Oh, M.D. is the Chief of the Division of Hematology and Medical Oncology; Professor of Medicine and Urology; and Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics at the Mount Sinai School ofMedicine and Associate Director for Clinical Research, The Tisch Cancer Institute.

Clinical Interests: Management of genitourinary malignancies, including prostate, renal, bladder, adrenocortical and testicular cancers.  
Research Interests: Dr. Oh's research interests include exploring the role of chemotherapy in both castration-resistant prostate cancer (CRPC) and localized high-risk prostate cancer.  In collaboration with laboratory-based colleagues, we are assessing changes in the expression of tissue and serum biomarkers due to chemotherapy.  Another area of interest relates to the role of secondary hormone therapies in the treatment of advanced prostate cancer.  

Another major research area has been the development and management of a prospective clinical database linked to blood and tissue banks for prostate cancer patients. Dr. Oh's recent research efforts exploring this database have included characterization of the efficacy of various therapies in advanced prostate cancer (e.g., nilutamide, ketoconazole, vinorelbine, docetaxel, mitoxantrone), assessment of PSA doubling time as a prognostic and predictive factor, efficacy of hormonal therapy, assessment of testosterone as a marker for cancer outcome, prediction of relapse based on nutritional factors at diagnosis and autoantibody signatures, and assessment of pharmacogenomic patterns predicting Gleason score.


In the News

Watch Dr. Oh discuss Advanced Prostate Cancer Care on WebMD.com.

Read about Dr. Oh in the NY Daily News "Daily Checkup"column -

"Men's age old problem: Prostate cancer hits many, but screening and new treatments lessen the danger"

PDF version: "Men's age old problem: Prostate cancer hits many, but screening and new treatments lessen the danger"


Medical Oncology

Clinical Focus

  • Adrenal Cortical Carcinoma
  • Bladder Cancer
  • Kidney Cancer
  • Medical Oncology


MD, New York University School of Medicine

Residency, General Medicine, Brigham and Women's Hospital, Harvard Medical School

Fellowship, Medical Oncology, Dana Farber Cancer Institute

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.